HomeOPK • NASDAQ
OPKO Health Inc
add
$1.35
0.74%
After Hours:(2.22%)+0.030
$1.38
Closed: Jul 11, 4:30:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 149.95M | -13.66% |
Operating expense | 78.95M | -13.82% |
Net income | -67.61M | 17.38% |
Net profit margin | -45.09 | 4.31% |
Earnings per share | -0.09 | — |
EBITDA | -43.68M | 4.32% |
Effective tax rate | 7.86% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 428.83M | 466.94% |
Total assets | 2.13B | 7.82% |
Total liabilities | 816.66M | 13.24% |
Total equity | 1.31B | — |
Shares outstanding | 793.05M | — |
Price to book | 0.70 | — |
Return on assets | -7.76% | — |
Return on capital | -9.14% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -67.61M | 17.38% |
Cash from operations | -34.55M | 2.85% |
Cash from investing | 40.53M | 1,022.14% |
Cash from financing | -4.02M | -119.51% |
Net change in cash | 4.06M | 120.07% |
Free cash flow | -94.36M | 18.77% |
Previous close
$1.36
Day range
$1.34 - $1.38
Year range
$1.21 - $2.04
Market cap
1.07B USD
Avg Volume
3.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". Wikipedia
Founded
1991
Headquarters
Website
Employees
2,997
